The peritumoural adipose tissue microenvironment and cancer. The roles of fatty acid binding protein 4 and fatty acid binding protein 5

Molecular and Cellular Endocrinology

Volumn 462, Issue , 2018, Pages 107-118

  Guaita Esteruelas, S ^a,b,c   Guma J ^b,c   Masana, L ^b   Borras J ^b,c  

^a INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^c HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

Adipose tissue; Cancer associated adipocytes; FABP4; FABP5; Lipid metabolism

Indexed keywords

ADIPOCYTOKINE; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 4; FATTY ACID BINDING PROTEIN 5; UNCLASSIFIED DRUG; FABP4 PROTEIN, HUMAN; FABP5 PROTEIN, HUMAN;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BROWN ADIPOSE TISSUE; CANCER CELL; CANCER GROWTH; CANCER PREVENTION; CANCER PROGNOSIS; CARCINOGENESIS; COLON CARCINOGENESIS; COLORECTAL CANCER; GLIOMA; HUMAN; LIPID METABOLISM; MALIGNANT NEOPLASM; MOUTH CANCER; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; TISSUE STRUCTURE; TUMOR MICROENVIRONMENT; UPREGULATION; WHITE ADIPOSE TISSUE; METABOLISM; NEOPLASM; PATHOLOGY;

ADIPOSE TISSUE; FATTY ACID-BINDING PROTEINS; HUMANS; NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 85013135275     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2017.02.002     Document Type: Article

References (165)

1. Adamson, J., Morgan, E.A., Beesley, C., Mei, Y., Foster, C.S., Fujii, H., Rudland, P.S., Smith, P.H., Ke, Y., High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity. Oncogene 22:18 (2003), 2739–2749 http://doi.org/10.1038/sj.onc.1206341.
2. Allen, M., Louise Jones, J., Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J. Pathol. 223:2 (2011), 162–176 http://doi.org/10.1002/path.2803.
3. Amor, S., Iglesias-de la Cruz, M.C., Ferrero, E., García-Villar, O., Barrios, V., Fernandez, N., Monge, L., García-Villalón, A.L., Granado, M., Peritumoral adipose tissue as a source of inflammatory and angiogenic factors in colorectal cancer. Feb Int. J. Colorectal Dis. 31:2 (2015), 365–375 http://doi.org/10.1007/s00384-015-2420-6.
4. Andarawewa, K.L., Motrescu, E.R., Chenard, M.P., Gansmuller, A., Stoll, I., Tomasetto, C., Rio, M.C., Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. Cancer Res. 65:23 (2005), 10862–10871 http://doi.org/10.1158/0008-5472.CAN-05-1231.
5. Aragonès, G., Ferré, R., Lázaro, I., Cabré, A., Plana, N., Merino, J., Heras, M., Girona, J., Masana, L., Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes. Atherosclerosis 213:1 (2010), 329–331 http://doi.org/ http://dx.doi.org/10.1016/j.atherosclerosis.2010.07.026.
6. Balkwill, F.R., Capasso, M., Hagemann, T., The tumor microenvironment at a glance. J. Cell Sci. 125:Pt 23 (2012), 5591–5596 http://doi.org/10.1242/jcs.116392.
7. Bernlohr, D.A., Simpson, M.A., Hertzel, A.V., Banaszak, L.J., Intracellular lipid-binding proteins and their genes. Annu. Rev. Nutr. 17 (1997), 277–303 http://doi.org/10.1146/annurev.nutr.17.1.277.
8. Berry, D.C., Levi, L., Noy, N., Holo-retinol-binding protein and its receptor STRA6 drive oncogenic transformation. Cancer Res. 74:21 (2014), 6341–6351 http://doi.org/10.1158/0008-5472.CAN-14-1052.
9. Bingle, L., Brown, N.J., Lewis, C.E., The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196:3 (2002), 254–265 http://doi.org/10.1002/path.1027.
10. Bochet, L., Meulle, A., Imbert, S., Salles, B., Valet, P., Muller, C., Cancer-associated adipocytes promotes breast tumor radioresistance. Biochem. Biophys. Res. Commun. 411:1 (2011), 102–106 http://doi.org/ http://dx.doi.org/10.1016/j.bbrc.2011.06.101.
11. Bochet, L., Lehuédé, C., Dauvillier, S., Wang, Y.Y., Dirat, B., Laurent, V., Dray, C., Guiet, R., Maridonneau-Parini, I., Le Gonidec, S., Couderc, B., Escourrou, G., Valet, P., Muller, C., Adipocyte-derived fibroblasts promote tumor progression and contribute to the desmoplastic reaction in breast cancer. Cancer Res. 73:18 (2013), 5657–5668 http://doi.org/10.1158/0008-5472.CAN-13-0530.
12. Boiteux, G., Lascombe, I., Roche, E., Plissonnier, M.L., Clairotte, A., Bittard, H., Fauconnet, S., A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells. Int. J. Cancer 124:8 (2009), 1820–1828 http://doi.org/10.1002/ijc.24112.
13. Booth, A., Magnuson, A., Fouts, J., Foster, M., Adipose tissue, obesity and adipokines: role in cancer promotion. Jan Horm. Mol. Biol. Clin. Investig. 21:1 (2015), 57–74, 10.1515/hmbci-2014-0037.
14. Bosquet, A., Guaita-Esteruelas, S., Saavedra, P., Rodríguez-calvo, R., Heras, M., Girona, J., Masana, L., Exogenous FABP4 induces endoplasmic reticulum stress in HepG2 liver cells. Atherosclerosis 249 (2016), 191–199 http://doi.org/10.1016/j.atherosclerosis.2016.04.012.
15. Bravo-Sagua, R., Mattar, P., Díaz, X., Lavandero, S., Cifuentes, M., Calcium sensing receptor as a novel mediator of adipose tissue dysfunction: mechanisms and potential clinical implications. Front. Physiol., 7(395), 2016 http://doi.org/10.3389/fphys.2016.00395.
16. Brindley, D.N., Lin, F.T., Tigyi, G.J., Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy. Biochim. Biophys. Acta 1831:1 (2013), 74–85 http://doi.org/10.1016/j.bbalip.2012.08.015.
17. Brown, K.A., Simpson, E.R., Obesity and breast cancer: progress to understanding the relationship. Cancer Res. 70:1 (2010), 4–7 http://doi.org/10.1158/0008-5472.CAN-09-2257.
18. Cabré, A., Lázaro, I., Girona, J., Manzanares, J.M., Marimon, F., Plana, N., Heras, M., Masana, L., Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. Atherosclerosis 195 (2007), 150–158 http://doi.org/10.1016/j.atherosclerosis.2007.04.045.
19. Cabré, A., Lázaro, I., Girona, J., Manzanares, J.M., Marimón, F., Plana, N., Heras, M., Masana, L., Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes. J. Lipid Res. 49:8 (2008), 1746–1751 http://doi.org/10.1194/jlr.M800102-JLR200.
20. Cabré, A., Lázaro, I., Girona, J., Manzanares, J.M., Marimón, F., Plana, N., Heras, M., Masana, L., Plasma fatty acid-binding protein 4 increases with renal dysfunction in type 2 diabetic patients without microalbuminuria. Clin. Chem. 54:1 (2008), 181–187 http://doi.org/10.1373/clinchem.2007.094672.
21. Cabré, A., Babio, N., Lázaro, I., Bulló, M., Garcia-Arellano, A., Masana, L., Salas-Salvadó, J., FABP4 predicts atherogenic dyslipidemia development. The PREDIMED study. Atherosclerosis 222:1 (2012), 229–234 http://doi.org/ http://dx.doi.org/10.1016/j.atherosclerosis.2012.02.003.
22. Calle, E.E., Kaaks, R., Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4:8 (2004), 579–591.
23. Campos, B., Centner, F.S., Bermejo, J.L., Ali, R., Dorsch, K., Wan, F., Felsberg, J., Ahmadi, R., Grabe, N., Reifenberger, G., Unterberg, A., Burhenne, J., Herold-Mende, C., Aberrant expression of retinoic acid signaling molecules influences patient survival in astrocytic gliomas. Am. J. Pathol. 178:5 (2011), 1953–1964 http://doi.org/10.1016/j.ajpath.2011.01.051.
24. Carnero, A., Lleonart, M., The hypoxic microenvironment: a determinant of cancer stem cell evolution. Bioessays. Jul;38. Suppl 1 (2016), S65–S74 http://doi:10.1002/bies.201670911.
25. Chen, R., Feng, C., Xu, Y., Cyclin-dependent kinase-associated protein Cks2 is associated with bladder cancer progression. J. Int. Med. Res. 39:2 (2011), 533–540.
26. Chkourko Gusky, H., Diedrich, J., MacDougald, O.A., Podgorski, I., Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression. Obes. Rev. 17:11 (2016), 1015–1029 http://doi.org/10.1111/obr.12450.
27. Cinti, S., The adipose organ at a glance. Dis. Model Mech. 5:5 (2012), 588–594 http://doi.org/10.1242/dmm.009662.
28. Clark, R., Krishnan, V., Schoof, M., Rodriguez, I., Theriault, B., Chekmareva, M., Rinker-Schaeffer, C., Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models. Am. J. Pathol. 183:2 (2013), 576–591 http://doi.org/10.1016/j.ajpath.2013.04.023.
29. Coleman, R.E., Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat. Rev. 27:3 (2001), 165–176 http://doi.org/10.1053/ctrv.2000.0210.
30. Coll, B., Cabre, A., Alonso-Villaverde, C., Lazaro, I., Aragonés, G., Parra, S., Girona, J., Masana, L., The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patients. Atherosclerosis 199:1 (2008), 147–153 http://doi.org/ http://dx.doi.org/10.1016/j.atherosclerosis.2007.09.032.
31. Cristancho, A.G., Lazar, M.A., Forming functional fat: a growing understanding of adipocyte differentiation. Sep. 28 Nat. Rev. Mol. Cell Biol. 12:11 (2011), 722–734 http://doi:10.1038/nrm3198.
32. Das, R., Hammamieh, R., Neill, R., Melhem, M., Jett, M., Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues. Clin. Cancer Res. 7:6 (2001), 1706–1715.
33. De Pergola, G., Silvestris, F., Obesity as a major risk factor for cancer. 2013:291546 J. Obes., 2013 http://doi.org/10.1155/2013/291546.
34. Dirat, B., Bochet, L., Escourrou, G., Valet, P., Muller, C., Unraveling the obesity and breast cancer links: a role for cancer-associated adipocytes?. Endocr. Dev. 19 (2010), 45–52 http://doi.org/10.1159/000316896.
35. Dirat, B., Bochet, L., Dabek, M., Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion cancer. Cancer Res., 2011, 2455–2465 http://doi.org/10.1158/0008-5472.CAN-10-3323.
36. Donohoe, C.L., Doyle, S.L., Reynolds, J.V., Visceral adiposity, insulin resistance and cancer risk. Diabetol. Metab. Syndr. 22 (2011), 3–12.
37. Donohoe, C.L., Lysaght, J., Sullivan, J.O., Reynolds, J.V., Emerging concepts linking obesity with the hallmarks of cancer. Trends Endocrinol. Metab., 2016, 1–17 http://doi.org/10.1016/j.tem.2016.08.004.
38. Doyle, S.L., Donohoe, C.L., Lysaght, J., Reynolds, J.V., Visceral obesity, metabolic syndrome, insulin resistance and cancer. Proc. Nutr. Soc. 71:1 (2012), 181–189 http://doi.org/doi:10.1017/S002966511100320X.
39. Ertunc, M.E., Sikkeland, J., Fenaroli, F., Griffiths, G., Daniels, M.P., Cao, H., Saatcioglu, F., Hotamisligil, G.S., Secretion of fatty acid binding protein aP2 from adipocytes through a nonclassical pathway in response to adipocyte lipase activity. J. Lipid Res. 56:2 (2015), 423–434 http://doi.org/10.1194/jlr.M055798.
40. Fang, L.Y., Wong, T.Y., Chiang, W.F., Chen, Y.L., Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma. J. Oral Pathol. Med. 39:4 (2010), 342–348 http://doi.org/10.1111/j.1600-0714.2009.00836.x.
41. Fazeli, M.S., Dashti, H., Akbarzadeh, S., Assadi, M., Aminian, A., Keramati, M.R., Nabipour, I., Circulating levels of novel adipocytokines in patients with colorectal cancer. Cytokine 62:1 (2013), 81–85 http://doi.org/10.1016/j.cyto.2013.02.012.
42. Finkelstein, E.A., Khavjou, O.A., Thompson, H., Trogdon, J.G., Pan, L., Sherry, B., Dietz, W., Obesity and severe obesity forecasts through 2030. Am. J. Prev. Med. 42:6 (2012), 563–570 http://doi.org/10.1016/j.amepre.2011.10.026.
43. Fujii, K., Kondo, T., Yokoo, H., Yamada, T., Iwatsuki, K., Hirohashi, S., Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye. Proteomics 5:5 (2005), 1411–1422 http://doi.org/10.1002/pmic.200401004.
44. Furuhashi, M., Hotamisligil, G.S., Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat. Rev. Drug Disc, 7(6), 2008, 489 http://doi.org/10.1038/nrd2589.
45. Furuhashi, M., Ishimura, S., Ota, H., Miura, T., Lipid chaperones and metabolic inflammation. 2011: 642612 Int. J. Inflam., 2011 http://doi.org/10.4061/2011/642612.
46. Furuhashi, M., Saitoh, S., Shimamoto, K., Miura, T., Fatty acid-binding protein 4 (FABP4): pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases. Clin. Med. Insights Cardiol. 8 (2014), 23–33, 10.4137/CMC.S17067 eCollection 2014.
47. Gerber, S.A., Rybalko, V.Y., Bigelow, C.E., Lugade, A.A., Foster, T.H., Frelinger, J.G., Lord, E.M., Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth. Am. J. Pathol. 169:5 (2006), 1739–1752 http://doi.org/10.2353/ajpath.2006.051222.
48. Girona, J., Rosales, R., Plana, N., Saavedra, P., Masana, L., Vallvé, J.C., FABP4 induces vascular smooth muscle cell proliferation and migration through a MAPK-dependent pathway. PLoS ONE, 8(11), 2013, e81914 http://doi.org/10.1371/journal.pone.0081914.
49. Gorbenko, O., Panayotou, G., Zhyvoloup, A., Volkova, D., Gout, I., Filonenko, V., Identification of novel PTEN-binding partners: PTEN interaction with fatty acid binding protein FABP4. Mol. Cell Biochem., 2010, 299–305 http://doi.org/10.1007/s11010-009-0312-1.
50. Grivennikov, S.I., Greten, F.R., Karin, M., Review immunity, inflammation, and cancer. Cell 140:6 (2010), 883–899 http://doi.org/10.1016/j.cell.2010.01.025.
51. Guaita-Esteruelas, S., Bosquet, A., Saavedra, P., Gumà, J., Girona, J., Lam, E.W.-F., Amillano, K., Borràs, J., Masana, L., Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins. Jan Mol. Carcinog. 56:1 (2016), 208–217 http://doi.org/10.1002/mc.22485.
52. Gucalp, A., Iyengar, N.M., Hudis, C.A., Dannenberg, A.J., Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression. Semin. Oncol. 43:1 (2016), 154–160 http://doi.org/10.1053/j.seminoncol.2015.09.012.
53. Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell 144:5 (2011), 646–674 http://doi.org/10.1016/j.cell.2011.02.013.
54. Hancke, K., Grubeck, D., Hauser, N., Kreienberg, R., Weiss, J.M., Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients. Breast Cancer Res. Treat. 119:2 (2010), 367–377 http://doi.org/10.1007/s10549-009-0577-9.
55. Harjes, U., Bridges, E., McIntyre, A., Fielding, B.A., Harris, A.L., Fatty acid binding protein 4, a point of convergence for angiogenic and metabolic signalling pathways in endothelial cells. Aug 15 J. Biol. Chem. 289:33 (2014), 23168–23176 http://doi.org/10.1074/jbc.M114.576512.
56. Harjes, U., Bridges, E., Gharpure, K.M., Roxanis, I., Sheldon, H., Miranda, F., Mangala, L.S., Pradeep, S., Lopez-Berestein, G., Ahmed, A., Fielding, B., Sood, A.K., Harris, A.L., Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4. Aug 29 Oncogene, 2016 http://doi.org/10.1038/onc.2016.256.
57. Hefetz-Sela, S., Scherer, P.E., Adipocytes: impact on tumor growth and potential sites for therapeutic intervention. Pharmacol. Ther. 138:2 (2013), 197–210 http://doi.org/ http://dx.doi.org/10.1016/j.pharmthera.2013.01.008.
58. Herroon, M.K., Rajagurubandara, E., Hardaway, A.L., Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms. Oncotarget 4:11 (2013), 2108–2123.
59. Hertzel, A.V., Bernlohr, D.A., The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function. Trends Endocrinol. Metab. 11:5 (2000), 175–180.
60. Horie, Y., Suzuki, A., Kataoka, E., Sasaki, T., Hamada, K., Sasaki, J., Mizuno, K., Hasegawa, G., Kishimoto, H., Iizuka, M., Naito, M., Enomoto, K., Watanabe, S., Mak, T.W., Nakano, T., Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J. Clin. Invest. 113:12 (2004), 1774–1783 http://doi.org/10.1172/JCI20513.
61. Hotamisligil, G.S., Bernlohr, D.A., Metabolic functions of FABPs-mechanisms and therapeutic implications. Nat. Rev. Endocrinol. 11:10 (2015), 592–605 http://doi.org/10.1038/nrendo.2015.122.
62. Hotamisligil, G.S., Johnson, R.S., Distel, R.J., Ellis, R., Papaioannou, V.E., Spiegelman, B.M., Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274:5291 (1996), 1377–1379.
63. Housa, D., Housová, J., Vernerová, Z., Haluzík, M., Adipocytokines and cancer. Physiol. Res. 55:3 (2006), 233–244.
64. Hovey, R.C., Aimo, L., Diverse and active roles for adipocytes during mammary gland growth and function. J. Mammary Gland. Biol. Neoplasia 15:3 (2010), 279–290 http://doi.org/10.1007/s10911-010-9187-8.
65. Huber, R., Meier, B., Otsuka, A., Fenini, G., Satoh, T., Gehrke, S., Widmer, D., Levesque, M.P., Mangana, J., Kerl, K., Gebhardt, C., Fujii, H., Nakashima, C., Nonomura, Y., Kabashima, K., Dummer, R., Contassot, E., French, L.E., Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophages. Sci. Rep., 18(6), 2016, 29914 http://doi.org/10.1038/srep29914.
66. Hursting, S.D., Digiovanni, J., Dannenberg, A.J., Azrad, M., Leroith, D., Demark-Wahnefried, W., Kakarala, M., Brodie, A., Berger, N.A., Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev. Res. 5:11 (2012), 1260–1272 http://doi.org/10.1158/1940-6207.CAPR-12-0140.
67. Ibarretxe, D., Girona, J., Amigó, N., Plana, N., Ferré, R., Guaita, S., Mallol, R., Heras, M., Masana, L., Impact of epidermal fatty acid binding protein on 2D-NMR-assessed atherogenic dyslipidemia and related disorders. J. Clin. Lipidol. 10:2 (2016), 330–338 http://doi.org/10.1016/j.jacl.2015.12.012.
68. Jeong, C.Y., Hah, Y.S., Cho, B.I., Lee, S.M., Joo, Y.T., Jung, E.J., Jeong, S.H., Lee, Y.J., Choi, S.K., Ha, W.S., Park, S.T., Hong, S.C., Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma. Oncol. Rep. 28:4 (2012), 1283–1292 http://doi.org/10.3892/or.2012.1922.
69. Jing, C., Beesley, C., Foster, C.S., Rudland, P.S., Fujii, H., Ono, T., Chen, H., Smith, P.H., Ke, Y., Identification of the messenger RNA for human cutaneous fatty acid-binding protein as a metastasis inducer. Cancer Res. 60:9 (2000), 2390–2398.
70. Kaaks, R., Berrino, F., Key, T., Rinaldi, S., Dossus, L., Biessy, C., Secreto, G., Amiano, P., Bingham, S., Boeing, H., Bueno de Mesquita, H.B., Chang-Claude, J., Clavel-Chapelon, F., Fournier, A., van Gils, C.H., Gonzalez, C.A., Gurrea, A.B., Critselis, E., Khaw, K.T., Krogh, V., Lahmann, P.H., Nagel, G., Olsen, A., Onland-Moret, N.C., Overvad, K., Palli, D., Panico, S., Peeters, P., Quirós, J.R., Roddam, A., Thiebaut, A., Tjønneland, A., Chirlaque, M.D., Trichopoulou, A., Trichopoulos, D., Tumino, R., Vineis, P., Norat, T., Ferrari, P., Slimani, N., Riboli, E., Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J. Natl. Cancer Inst. 97:10 (2005), 755–765 http://doi.org/10.1093/jnci/dji132.
71. Kalluri, R., Zeisberg, M., Fibroblasts in cancer. Nat. Rev. Cancer 6:5 (2006), 392–401 http://doi.org/10.1038/nrc1877.
72. Kannan-Thulasiraman, P., Seachrist, D.D., Mahabeleshwar, G.H., Jain, M.K., Noy, N., Fatty acid-binding protein 5 and PPARbeta/delta are critical mediators of epidermal growth factor receptor-induced carcinoma cell growth. J. Biol. Chem. 285:25 (2010), 19106–19115 http://doi.org/10.1074/jbc.M109.099770.
73. Kawaguchi, K., Kinameri, A., Suzuki, S., Senga, S., Ke, Y., Fujii, H., The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis. Biochem. J. 473:4 (2016), 449–461 http://doi.org/10.1042/BJ20150926.
74. Kawaguchi, K., Senga, S., Kubota, C., Kawamura, Y., Ke, Y., Fujii, H., High expression of Fatty Acid-Binding Protein 5 promotes cell growth and metastatic potential of colorectal cancer cells. FEBS Open Bio, 6(3), 2016 http://doi.org/10.1002/2211-5463.12031.
75. Khandekar, M.J., Cohen, P., Spiegelman, B.M., Molecular mechanisms of cancer development in obesity. Nat. Rev. Cancer 24:11(12) (2011), 886–895, 10.1038/nrc3174.
76. Kim, S., Lee, Y., Koo, J.S., Differential expression of lipid metabolism-related proteins in different breast cancer subtypes. PLoS ONE, 10(3), 2015, e0119473 http://doi.org/10.1371/journal.pone.0119473.
77. Komohara, Y., Jinushi, M., Takeya, M., Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci. 105:1 (2014), 1–8 http://doi.org/10.1111/cas.12314.
78. Koshiyama, A., Ichibangase, T., Imai, K., Comprehensive fluorogenic derivatization-liquid chromatography/tandem mass spectrometry proteomic analysis of colorectal cancer cell to identify biomarker candidate. Biomed. Chromatogr. 27:4 (2013), 440–450 http://doi.org/10.1002/bmc.2811.
79. Kuchuk, I., Hutton, B., Moretto, P., Ng, T., Addison, C.L., Clemons, M., Incidence, consequences and treatment of bone metastases in breast cancer patients-Experience from a single cancer centre. J. Bone Oncol. 2:4 (2013), 137–144 http://doi.org/10.1016/j.jbo.2013.09.001.
80. Lapeire, L., Hendrix, A., Lambein, K., Van Bockstal, M., Braems, G., Van Den Broecke, R., Limame, R., Mestdagh, P., Vandesompele, J., Vanhove, C., Maynard, D., Lehuédé, C., Muller, C., Valet, P., Gespach, C.P., Bracke, M., Cocquyt, V., Denys, H., De Wever, O., Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak/STAT3 signaling. Cancer Res. 74:23 (2014), 6806–6819 http://doi.org/10.1158/0008-5472.CAN-14-0160.
81. Laurent, V., Guérard, A., Mazerolles, C., Le Gonidec, S., Toulet, A., Nieto, L., Zaidi, F., Majed, B., Garandeau, D., Socrier, Y., Golzio, M., Cadoudal, T., Chaoui, K., Dray, C., Monsarrat, B., Schiltz, O., Wang, Y.Y., Couderc, B., Valet, P., Malavaud, B., Muller, C., Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity. Nat. Commun., 7(10230), 2016 http://doi.org/10.1038/ncomms10230.
82. Lázaro, I., Díaz, M., Cabré, A., Masana, L., Ibáñez, L., Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess. Gynecol. Endocrinol., 2011, 1–5 http://doi.org/10.3109/09513590.2011.569608.
83. Lázaro, I., Ferré, R., Plana, N., Aragonès, G., Girona, J., Merino, J., Heras, M., Cabré, A., Masana, L., Lifestyle changes lower FABP4 plasma concentration in patients with cardiovascular risk. Rev. Española Cardiol. 65:2 (2012), 152–157.
84. Lee, Y.H., Mottillo, E.P., Granneman, J.G., Adipose tissue plasticity from WAT to BAT and in between. Biochim. Biophys. Acta 1842:3 (2014), 358–369 http://doi.org/10.1016/j.bbadis.2013.05.011.
85. Levi, L., Lobo, G., Doud, M.K., von Lintig, J., Seachrist, D., Tochtrop, G.P., Noy, N., Genetic ablation of the fatty acid-binding protein FABP5 suppresses HER2-induced mammary tumorigenesis. Cancer Res. 73:15 (2013), 4770–4780 http://doi.org/10.1158/0008-5472.CAN-13-0384.
86. Liu, R.Z., Graham, K., Glubrecht, D.D., Germain, D.R., Mackey, J.R., Godbout, R., Association of FABP5 expression with poor survival in triple-negative breast cancer: implication for retinoic acid therapy. Am. J. Pathol. 178:3 (2011), 997–1008 http://doi.org/10.1016/j.ajpath.2010.11.075.
87. Liu, R.Z., Garcia, E., Glubrecht, D.D., Poon, H.Y., Mackey, J.R., Godbout, R., CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid. Jul 5 Mol. Cancer, 14, 2015, 129 http://doi.org/10.1186/s12943-015-0380-7.
88. Liu, Y., Metzinger, M.N., Lewellen, K.A., Cripps, S.N., Carey, K.D., Harper, E.I., Shi, Z., Tarwater, L., Grisoli, A., Lee, E., Slusarz, A., Yang, J., Loughran, E.A., Conley, K., Johnson, J.J., Klymenko, Y., Bruney, L., Liang, Z., Dovichi, N.J., Cheatham, B., Leevy, W.M., Stack, M.S., Obesity contributes to ovarian cancer metastatic success through increased lipogenesis, enhanced vascularity, and decreased infiltration of M1 macrophages. Cancer Res. 75:23 (2015), 5046–5057 http://doi.org/10.1158/0008-5472.CAN-15-0706.
89. Maeda, K., Uysal, K.T., Makowski, L., Görgün, C.Z., Atsumi, G., Parker, R.A., Brüning, J., Hertzel, A.V., Bernlohr, D.A., Hotamisligil, G.S., Role of the fatty acid binding protein mal1 in obesity and insulin resistance. Diabetes 52:2 (2003), 300–307.
90. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., Sica, A., Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Nov Trends Immunol. 23:11 (2002), 549–555.
91. Masouyé, I., Saurat, J.H., Siegenthaler, G., Epidermal fatty-acid-binding protein in psoriasis, basal and squamous cell carcinomas: an immunohistological study. Dermatology 192:3 (1996), 208–213.
92. Meng, L., Zhou, J., Sasano, H., Suzuki, T., Zeitoun, K.M.B.S., Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction. Cancer Res. 61:5 (2001), 2250–2255.
93. Merdad, A., Karim, S., Schulten, H.J., Jayapal, M., Dallol, A., Buhmeida, A., Al-Thubaity, F., GariI, M.A., Chaudhary, A.G., Abuzenadah, A.M., Al-Qahtani, M.H., Transcriptomics profiling study of breast cancer from Kingdom of Saudi Arabia revealed altered expression of Adiponectin and Fatty Acid Binding Protein4: is lipid metabolism associated with breast cancer?. BMC Genomics, 16(Suppl. 1), 2015, S11 http://doi.org/10.1186/1471-2164-16-S1-S11.
94. Mita, T., Furuhashi, M., Hiramitsu, S., Ishii, J., Hoshina, K., Ishimura, S., Fuseya, T., Watanabe, Y., Tanaka, M., Ohno, K., Akasaka, H., Ohnishi, H., Yoshida, H., Saitoh, S., Shimamoto, K., Miura, T., FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and Guanylyl cyclase-PKG-dependent lipolytic mechanisms. Feb Obesity 23:2 (2015), 359–367, 10.1002/oby.20954 http://doi.org/10.1002/oby.20954.
95. Moolenaar, W.H., Perrakis, A., Insights into autotaxin: how to produce and present a lipid mediator. Nat. Rev. Mol. Cell Bio 12 (2011), 674–679.
96. Morgan, E.A., Forootan, S.S., Adamson, J., Foster, C.S., Fujii, H., Igarashi, M., Beesley, C., Smith, P.H., Ke, Y., Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: potential prognostic marker and target for tumourigenicity-suppression. Int. J. Oncol. 32:4 (2008), 767–775.
97. Morgan, E., Kannan-Thulasiraman, P., Noy, N., Involvement of fatty acid binding protein 5 and PPARβ/δ in prostate cancer cell growth. PPAR Res., 2010 234629 http://doi.org/10.1155/2010/234629.
98. Morris, E.V., Edwards, C.M., Bone marrow adipose tissue: a new player in cancer metastasis to bone. Front. Endocrinol., 7(90), 2016 http://doi.org/10.3389/fendo.2016.00090.
99. Motrescu, E.R., Rio, M.C., Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle. Biol. Chem. 389:8 (2008), 1037–1041 http://doi.org/10.1515/BC.2008.110.
100. Muppalla, J.N.K., Muddana, K., Dorankula, S.P.R., Thokala, M.R., Pasupula, A.P., Microenvironment-a role in tumour progression and prognosis. J. Clin. Diagn Res. 7:9 (2013), 2096–2099 http://doi.org/10.7860/JCDR/2013/6619.3419.
101. Myers, J.S., von Lersner, A.K., Sang, Q.X.A., Proteomic upregulation of fatty acid synthase and fatty acid binding protein 5 and identification of cancer- and Race-specific pathway associations in human prostate cancer tissues. J. Cancer 7:11 (2016), 1452–1464 http://doi.org/10.7150/jca.15860.
102. Nieman, K.M., Kenny, H.A., Penicka, C.V., Ladanyi, A., Buell-gutbrod, R., Zillhardt, M.R., Romero, I.L., Carey, M.S., Mills, G.B., Hotamisligil, G.S., Yamada, S.D., Peter, M.E., Gwin, K., Lengyel, E., Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Oct 30 Nat. Med. 17:11 (2011), 1498–1503 http://doi.org/10.1038/nm.2492.
103. Nieman, K.M., Romero, I.L., Houten, B Van, Lengyel, E., Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim. Biophys. Acta 1831:10 (2013), 1533–1541 http://doi.org/10.1016/j.bbalip.2013.02.010.
104. Nimptsch, K., Pischon, T., Body fatness, related biomarkers and cancer risk: an epidemiological perspective. May Horm. Mol. Biol. Clin. Investig. 22:2 (2015), 39–51 http://doi.org/10.1515/hmbci-2014-0043.
105. Noy, N., Li, L., Abola, M.V., Berger, N.A., Is retinol binding protein 4 a link between adiposity and cancer?. Horm. Mol. Biol. Clin. Investig. 23:2 (2015), 39–46 http://doi.org/10.1515/hmbci-2015-0019.
106. Olsson, A., Nakhlé, J., Sundstedt, A., Plas, P., Bauchet, A.L., Pierron, V., Bruetschy, L., Deronic, A., Törngren, M., Liberg, D., Schmidlin, F., Leanderson, T., Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment. J. Immunother. Cancer, 3, 2015, 53 http://doi.org/10.1186/s40425-015-0098-5.
107. Panno, M.L., Naimo, G.D., Spina, E., Andò, S., Mauro, L., Different molecular signaling sustaining adiponectin action in breast cancer. Dec Curr. Opin. Pharmacol. 31 (2016), 1–7 http://doi.org/10.1016/j.coph.2016.08.001.
108. Parkin, D.M., Boyd, L., Cancers attributable to overweight and obesity in the UK in 2010. Br. J. Cancer 6:105 Suppl. 2 (2011), S34–S37.
109. Pellegrinelli, V., Carobbio, S., Vidal-Puig, A., Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues. Diabetologia 59:6 (2016), 1075–1088 http://doi.org/10.1007/s00125-016-3933-4.
110. Pepe, J., Cipriani, C., Cilli, M., Colangelo, L., Minisola, S., Adipokines and bone metabolism: an interplay to untangle. Nov J. Endocrinol. Invest. 39:11 (2016), 1359–1361 http://doi.org/10.1007/s40618-016-0549-y.
111. Petrova, D.T., Asif, A.R., Armstrong, V.W., Dimova, I., Toshev, S., Yaramov, N., Oellerich, M., Toncheva, D., Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer. Clin. Biochem. 41:14–15 (2008), 1224–1236 http://doi.org/10.1016/j.clinbiochem.2008.07.012.
112. Pollard, J.W., Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4:1 (2004), 71–78 http://doi.org/10.1038/nrc1256.
113. Pollard, J.W., Macrophages define the invasive microenvironment in breast cancer. J. Leukoc. Biol. 84:3 (2008), 623–630 http://doi.org/10.1189/jlb.1107762.
114. Powell, C.A., Nasser, M.W., Zhao, H., Wochna, J.C., Zhang, X., Shapiro, C., Shilo, K., Ganju, R.K., Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability. Oncotarget 6:8 (2015), 6373–6385 http://doi.org/10.18632/oncotarget.3442.
115. Prieto-Hontoria, P.L., Pérez-Matute, P., Fernández-Galilea, M., Bustos, M., Martínez, J.A., Moreno-Aliaga, M.J., Role of obesity-associated dysfunctional adipose tissue in cancer: a molecular nutrition approach. Biochim. Biophys. Acta 1807:6 (2011), 664–678 http://doi.org/ http://dx.doi.org/10.1016/j.bbabio.2010.11.004.
116. Queen, M.M., Ryan, R.E., Holzer, R.G., Keller-Peck, C.R., Jorcyk, C.L., Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. Cancer Res. 65:19 (2005), 8896–8904 http://doi.org/10.1158/0008-5472.CAN-05-1734.
117. Ravacci, G.R., Brentani, M.M., Tortelli, T.C., Torrinhas, R.S., Santos, J.R., Logullo, A.F., Waitzberg, D.L., Docosahexaenoic acid modulates a HER2-associated lipogenic phenotype, induces apoptosis, and increases trastuzumab action in HER2-overexpressing breast carcinoma cells. 2015:838652 Biomed. Res. Int., 2015, 10.1155/2015/838652.
118. Renehan, A.G., Tyson, M., Egger, M., Heller, R.F., Zwahlen, M., Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:9612 (2008), 569–578 http://doi.org/10.1016/S0140-6736(08)60269-X.
119. Ribeiro, R.J.T., Monteiro, C.P.D., Cunha, V.F.P.M., Azevedo, A.S.M., Oliveira, M.J., Monteiro, R., Fraga, A.M., Príncipe, P., Lobato, C., Lobo, F., Morais, A., Silva, V., Sanches-Magalhães, J., Oliveira, J., Guimarães, J.T., Lopes, C.M., Medeiros, R.M., Tumor cell-educated periprostatic adipose tissue acquires an aggressive cancer-promoting secretory profile. Cell Physiol. Biochem. 29:1–2 (2012), 233–240 http://doi.org/10.1159/000337604.
120. Ribeiro, R., Monteiro, C., Catalán, V., Hu, P., Cunha, V., Rodríguez, A., Gómez-Ambrosi, J., Fraga, A., Príncipe, P., Lobato, C., Lobo, F., Morais, A., Silva, V., Sanches-Magalhães, J., Oliveira, J., Pina, F., Lopes, C., Medeiros, R., Frühbeck, G., Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue. BMC Med., 10(1), 2012, 108 http://doi.org/10.1186/1741-7015-10-108.
121. Saavedra, P., Girona, J., Bosquet, A., Guaita, S., Canela, N., Aragonès, G., Heras, M., Masana, L., New insights into circulating FABP4: interaction with cytokeratin 1 on endothelial cell membranes. Biochim. Biophys. Acta 1853:11 (2015), 2966–2974 http://doi.org/10.1016/j.bbamcr.2015.09.002.
122. Sanchez-Gurmaches, J., Guertin, D.A., Adipocyte lineages: tracing back the origins of fat. Biochim. Biophys. Acta 1842:3 (2014), 340–351 http://doi.org/10.1016/j.bbadis.2013.05.027.
123. Schlottmann, I., Ehrhart-Bornstein, M., Wabitsch, M., Bornstein, S.R., Lamounier-Zepter, V., Calcium-dependent release of adipocyte fatty acid binding protein from human adipocytes. Int. J. Obes. 38:9 (2014), 1221–1227 http://doi.org/10.1038/ijo.2013.241.
124. Schmidt, S., Monk, J.M., Robinson, L.E., Mourtzakis, M., The integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: potential effects of exercise. June Obes. Rev. 16:6 (2015), 473–487 http://doi.org/10.1111/obr.12281.
125. Schug, T.T., Berry, D.C., Shaw, N.S., Travis, S.N., Noy, N., Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 129:4 (2007), 723–733 http://doi.org/10.1016/j.cell.2007.02.050.
126. Schug, T.T., Berry, D.C., Toshkov, I.A., Cheng, L., Nikitin, A.Y., Noy, N., Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR. Proc. Natl. Acad. Sci. 105:21 (2008), 7546–7551 http://doi.org/10.1073/pnas.0709981105.
127. Shafat, M.S., Oellerich, T., Mohr, S., Robinson, S.D., Edwards, D.R., Marlein, C.R., Piddock, R.E., Fenech, M., Zaitseva, L., Abdul-Aziz, A., Turner, J., Watkins, J.A., Lawes, M., Bowles, K.M., Rushworth, S.A., Leukemic blasts program bone marrow adipocytes to generate a pro-tumoral microenvironment. Blood, 2017 blood-2016-08-734798 http://doi.org/10.1182/blood-2016-08-734798.
128. Sica, A., Larghi, P., Mancino, A., Rubino, L., Porta, C., Totaro, M.G., Rimoldi, M., Biswas, S.K., Allavena, P., Mantovani, A., Macrophage polarization in tumour progression. Semin. Cancer Biol. 18:5 (2008), 349–355 http://doi.org/10.1016/j.semcancer.2008.03.004.
129. Simon, M.C., The hypoxia response pathways - hats off!. N. Engl. J. Med., 2016 Sep. 13 http://doi.org/10.1056/NEJMcibr1610065.
130. Sinha, P., Hütter, G., Köttgen, E., Dietel, M., Schadendorf, D., Lage, H., Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-sigma (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas. Electrophoresis 20:14 (1999), 2952–2960 http://doi.org/10.1002/(SICI)1522-2683(19991001)20:14%3c2952::AID-ELPS2952%3e3.0.CO;2-H.
131. Smathers, R.L., Petersen, D.R., The human fatty acid-binding protein family: evolutionary divergences and functions. Hum. Genomics 5:3 (2011), 170–191.
132. Sousa, S., Brion, R., Lintunen, M., Kronqvist, P., Sandholm, J., Mönkkönen, J., Kellokumpu-Lehtinen, P.L., Lauttia, S., Tynninen, O., Joensuu, H., Heymann, D., Määttä, J.A., Human breast cancer cells educate macrophages toward the M2 activation status. Breast Cancer Res., 17, 2015, 101 http://doi.org/10.1186/s13058-015-0621-0.
133. Stanford, K.I., Middelbeek, R.J.W., Townsend, K.L., Lee, M.Y., Takahashi, H., So, K., Hitchcox, K.M., Markan, K.R., Hellbach, K., Hirshman, M.F., Tseng, Y.H., Goodyear, L.J., A novel role for subcutaneous adipose tissue in exercise-induced improvements in glucose homeostasis. Diabetes 64:6 (2015), 2002–2014 http://doi.org/10.2337/db14-0704.
134. Storch, J., Corsico, B., The emerging functions and mechanisms of mammalian fatty acid – binding proteins. Annu. Rev. Nutr. 28 (2008), 73–95 http://doi.org/10.1146/annurev.nutr.27.061406.093710.
135. Sturtz, L.A., Deyarmin, B., van Laar, R., Yarina, W., Shriver, C.D., Ellsworth, R.E., Gene expression differences in adipose tissue associated with breast tumorigenesis. Adipocyte 3:2 (2014), 107–114.
136. Sulis, M.L., Parsons, R., PTEN: from pathology to biology. Trends Cell Biol. 13:9 (2003), 478–483 http://doi.org/10.1016/S0962-8924(03)00175-2.
137. Tan, J., Buache, E., Chenard, M.P., Dali-Youcef, N., Rio, M.C., Adipocyte is a non-trivial, dynamic partner of breast cancer cells. Int. J. Dev. Biol. 55:7–9 (2011), 851–859 http://doi.org/10.1387/ijdb.113365jt.
138. Tang, Z., Shen, Q., Xie, H., Zhou, X., Li, J., Feng, J., Liu, H., Wang, W., Zhang, S., Ni, S., Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC). Oncotarget, 2016 http://doi.org/10.18632/oncotarget.10086.
139. Teoh, S.L., Das, S., Tumour biology of obesity-related cancers: understanding the molecular concept for better diagnosis and treatment. Nov Tumour Biol. 37:11 (2016), 14363–14380 http://doi.org/10.1007/s13277-016-5357-7.
140. Thulasiraman, P., McAndrews, D.J., Mohiudddin, I.Q., Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells. BMC Cancer, 14(724), 2014 http://doi.org/10.1186/1471-2407-14-724.
141. Tilg, H., Moschen, A.R., Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6:10 (2006), 772–783 http://doi.org/10.1038/nri1937.
142. Tilg, H., Moschen, A.R., Inflammatory mechanisms in the regulation of insulin resistance. Mol. Med. 14:April (2008), 222–231 http://doi.org/10.2119/2007-00119.Tilg.
143. Tölle, A., Suhail, S., Jung, M., Jung, K., Stephan, C., Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma. BMC Cancer, 11(1), 2011, 302 http://doi.org/10.1186/1471-2407-11-302.
144. Trevellin, E., Scarpa, M., Carraro, A., Lunardi, F., Kotsafti, A., Porzionato, A., Saadeh, L., Cagol, M., Alfieri, R., Tedeschi, U., Calabrese, F., Castoro, C., Vettor, R., Esophageal adenocarcinoma and obesity: peritumoral adipose tissue plays a role in lymph node invasion. Oncotarget 6:13 (2015), 11203–11215 http://doi.org/10.18632/oncotarget.3587.
145. Tsuda, M., Inoue-Narita, T., Suzuki, A., Itami, S., Blumenberg, M., Manabe, M., Induction of gene encoding FABP4 in Pten-null keratinocytes. FEBS Lett. 583:8 (2009), 1319–1322 http://doi.org/10.1016/j.febslet.2009.03.030.
146. Tucker, S.L., Herbrich, S.M., Unruh, A.K., Nick, A.M., Crane, E.K., Coleman, R.L., Guenthoer, J., Dalton, H.J., Wu, S.Y., Rupaimoole, R., Lopez-Berestein, G., Ozpolat, B., Ivan, C., Hu, W., Baggerly, K.A., Sood, A.K., Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer. Apr 22 Clin. Cancer Res., 2014.
147. Uehara, H., Takahashi, T., Oha, M., Ogawa, H., Izumi, K., Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression. Dec 1 Int. J. Cancer 135:11 (2014), 2558–2568 http://doi.org/10.1002/ijc.28903.
148. van Kruijsdijk, R.C., van der Wall, E., Visseren, F.L., Obesity and Cancer: the role of dysfunctional adipose tissue. Oct Cancer Epidemiol. Biomarkers Prev. 18:10 (2009), 2569–2579 http://doi.org/10.1158/1055-9965.EPI-09-0372.
149. Vona-Davis, L., Gibson, L.F., Adipocytes as a critical component of the tumor microenvironment. Leuk. Res. 37:5 (2013), 483–484 http://doi.org/ http://dx.doi.org/10.1016/j.leukres.2013.01.007.
150. Vona-Davis, L., Rose, D.P., Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr. Relat. Cancer 14:2 (2007), 189–206 http://doi.org/10.1677/ERC-06-0068.
151. Wagner, M., Bjerkvig, R., Wiig, H., Dudley, A.C., Loss of adipocyte specification and necrosis augment tumor-associated inflammation. Adipocyte 2:3 (2013), 176–183 http://doi.org/10.4161/adip.24472.
152. Wang, Y., Beydoun, M.A., Liang, L., Caballero, B., Kumanyika, S.K., Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic. Obesity 16:10 (2008), 2323–2330 http://doi.org/10.1038/oby.2008.351.
153. Wang, F., Gao, S., Chen, F., Fu, Z., Yin, H., Lu, X., Yu, J., Lu, C., Mammary fat of breast cancer: gene expression profiling and functional characterization. PloS One, 9(10), 2014, e109742 http://doi.org/10.1371/journal.pone.0109742.
154. Wang, W., Jia, H.L., Huang, J.M., Liang, Y.C., Tan, H., Geng, H.Z., Guo, L.Y., Yao, S.Z., Identification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics. Br. J. Cancer 110:7 (2014), 1748–1758 http://doi.org/10.1038/bjc.2014.92.
155. Wang, W., Yuan, P., Yu, D., Du, F., Zhu, A., Li, Q., Zhang, P., Lin, D., Xu, B., A single-nucleotide polymorphism in the 3′-UTR region of the adipocyte fatty acid binding protein 4 gene is associated with prognosis of triple-negative breast cancer. Oncotarget, 2014 http://doi.org/10.18632/oncotarget.7920.
156. Wang, C., Gao, C., Meng, K., Qiao, H., Wang, Y., Human adipocytes stimulate invasion of breast cancer MCF-7 cells by secreting IGFBP-2. PloS One, 10(3), 2015, e0119348 http://doi.org/10.1371/journal.pone.0119348.
157. Wang, J., Yang, D.L., Chen, Z.Z., Gou, B.F., Associations of body mass index with cancer incidence among populations, genders, and menopausal status: a systematic review and meta-analysis. Cancer Epidemiol. 42 (2016), 1–8 http://doi.org/10.1016/j.canep.2016.02.010.
158. Wang, W., Chu, H.J., Liang, Y.C., Huang, J.M., Shang, C.L., Tan, H., Liu, D., Zhao, Y.H., Liu, T.Y., Yao, S.Z., FABP5 correlates with poor prognosis and promotes tumor cell growth and metastasis in cervical cancer. 2016 Nov Tumour Biol. 37:11 (2016), 14873–14883 http://doi.org/10.1007/s13277-016-5350-1.
159. Watanabe, R., Fujii, H., Yamamoto, A., Hashimoto, T., Kameda, K., Ito, M., Ono, T., Immunohistochemical distribution of cutaneous fatty acid-binding protein in human skin. J. Dermatol Sci. 16:1 (1997), 17–22.
160. WHO, Obesity and Overweight. World Health Organization, 2016 http://www.who.int/mediacentre/factsheets/fs311/en/.
161. Xu, A., Wang, Y., Xu, J.Y., Stejskal, D., Tam, S., Zhang, J., Wat, N.M., Wong, W.K., Lam, K.S., Adipocyte fatty acid–binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin. Chem. 52:3 (2006), 405–413 http://doi.org/10.1373/clinchem.2005.062463.
162. Yeung, D.C., Xu, A., Tso, A.W., Chow, W.S., Wat, N.M., Fong, C.H., Tam, S., Sham, P.C., Lam, K.S., Circulating levels of adipocyte and epidermal fatty acid-binding proteins in relation to nephropathy staging and macrovascular complications in type 2 diabetic patients. Diabetes Care 32:1 (2009), 132–134 http://doi.org/10.2337/dc08-1333.
163. Zhang, C., Rexrode, K.M., van Dam, R.M., Li, T.Y., Hu, F.B., Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 117:13 (2008), 1658–1667 http://doi.org/10.1161/CIRCULATIONAHA.107.739714.
164. Zhang, W., Levi, L., Banerjee, P., Jain, M., Noy, N., Kruppel-like factor 2 suppresses mammary carcinoma growth by regulating retinoic acid signaling. Oncotarget 6:34 (2015), 35830–35842 http://doi.org/10.18632/oncotarget.5767.
165. Zhou, L., Zhao, Y., Wang, X., Jiang, S., Li, H., Expression of fatty acid synthase and adipocyte fatty acid-binding protein and the relationship with the clinicopathological characteristics in human infiltrating ductal breast cancer. 2015 Mar Sichuan Da Xue Xue Bao Yi Xue Ban. 46:2 (2015), 228–233.